A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 35/20 (2006.01) A61P 35/00 (2006.01) A61P 39/00 (2006.01)
Patent
CA 2639562
A cysteine-rich undenatured whey-derived protein formulation did not interfere with the tumor-cytotoxic effects of chemotherapy and radiation therapy and did not have a negative effect on the clinical outcome, that is, negatively affect survival and increase mortality. Indeed, use of a high-cysteine undenatured whey derived protein in the treatment of cancer patients resulted in an increase in patient survival.
Bounous Gustavo
Droge Wulf
Molson John H.
2458781 Canada Inc.
Bounous Gustavo
Droge Wulf
Gowling Lafleur Henderson Llp
Molson John H.
LandOfFree
Use of cysteine-rich whey derived protein in patients... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of cysteine-rich whey derived protein in patients..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cysteine-rich whey derived protein in patients... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2083042